Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer (NSCLC) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The non-small cell lung cancer...
-
Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Oncology Devices Market Report 2026" has been added to ResearchAndMarkets.com's offering.The oncology devices market has witnessed significant...
-
Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future...
-
Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Lung Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and...
-
Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Next Generation Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
-
Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Brain Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
-
Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Head and Neck Cancer Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
-
4D Path to participate as exploratory biomarker collaborator in Phase II DAD-IO clinical study (NCT04724018) led by DFCI and supported by Gilead Sciences
-
4D Path has announced a collaboration with AMD and Oracle to advance predictive oncology and accelerate clinical trials.
-
Dublin, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The "DNA Diagnostics Market - Global Outlook & Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering.The DNA Diagnostics Market was...